[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE418877T1 - Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung - Google Patents

Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung

Info

Publication number
ATE418877T1
ATE418877T1 AT02736016T AT02736016T ATE418877T1 AT E418877 T1 ATE418877 T1 AT E418877T1 AT 02736016 T AT02736016 T AT 02736016T AT 02736016 T AT02736016 T AT 02736016T AT E418877 T1 ATE418877 T1 AT E418877T1
Authority
AT
Austria
Prior art keywords
drinkable
edible
body temperature
amino acid
acid composition
Prior art date
Application number
AT02736016T
Other languages
English (en)
Inventor
Takashi Abe
Hajime Tsunoo
Masayuki Uchida
Takae Wakabayashi
Hiroshi Tsuchita
Original Assignee
Riken
Takashi Abe
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken, Takashi Abe, Meiji Dairies Corp filed Critical Riken
Application granted granted Critical
Publication of ATE418877T1 publication Critical patent/ATE418877T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Seeds, Soups, And Other Foods (AREA)
AT02736016T 2001-06-08 2002-06-06 Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung ATE418877T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001173983 2001-06-08

Publications (1)

Publication Number Publication Date
ATE418877T1 true ATE418877T1 (de) 2009-01-15

Family

ID=19015340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02736016T ATE418877T1 (de) 2001-06-08 2002-06-06 Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung

Country Status (13)

Country Link
US (1) US20040235923A1 (de)
EP (1) EP1402788B1 (de)
JP (1) JP4128524B2 (de)
KR (2) KR100753879B1 (de)
CN (1) CN100464647C (de)
AT (1) ATE418877T1 (de)
AU (1) AU2008203461B2 (de)
CA (1) CA2449917C (de)
DE (1) DE60230621D1 (de)
HK (1) HK1064566A1 (de)
NZ (2) NZ587048A (de)
TW (1) TWI328450B (de)
WO (1) WO2002100193A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006191933A (ja) * 2003-05-19 2006-07-27 Ajinomoto Co Inc いびき又は睡眠時の呼吸障害の予防・治療剤
WO2006049286A1 (ja) * 2004-11-02 2006-05-11 Ajinomoto Co., Inc. アレルギー性疾患予防・治療剤
MX2007005136A (es) * 2004-11-02 2007-08-02 Oragenics Inc Metodos para regular el peso y el tamano de los animales con glicina.
WO2007029730A1 (ja) * 2005-09-06 2007-03-15 Meiji Dairies Corporation 老人性貧血を防止又は治療するためのアミノ酸組成物
JPWO2007060924A1 (ja) * 2005-11-22 2009-05-07 味の素株式会社 膵β細胞保護剤
JP5502480B2 (ja) * 2006-09-18 2014-05-28 コンピュゲン エルティーディー. 生物活性ペプチド及びその使用方法
US20080268038A1 (en) * 2007-04-26 2008-10-30 Wolfe Robert R Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
JP5565016B2 (ja) * 2009-04-08 2014-08-06 ライオン株式会社 低体温改善用組成物及び冷え性改善用組成物
CN103181920A (zh) * 2011-12-28 2013-07-03 吴顺字 一种防癌植物油的配方
JP6423717B2 (ja) * 2012-05-07 2018-11-14 株式会社明治 非糖質性エネルギー産生増強剤
JP2016102064A (ja) * 2013-08-14 2016-06-02 株式会社明治 脂質代謝促進剤
US9629889B2 (en) * 2014-10-22 2017-04-25 Khanh Le Aqueous solution formulated to raise body temperature
CN106417597A (zh) * 2016-08-30 2017-02-22 新疆阜丰生物科技有限公司 一种适用于乳酸菌饮料的复合稳定剂
JP2017088616A (ja) * 2017-02-09 2017-05-25 株式会社東洋新薬 黒生姜含有組成物
PL235153B1 (pl) * 2017-06-02 2020-06-01 Gbj Pharma Spolka Z Ograniczona Odpowiedzialnoscia Farmaceutyczna kompozycja żywieniowa dla pacjentów z odleżynami

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85105574A (zh) * 1985-01-17 1987-01-14 四川大学 从牲畜血液中提制复合氨基酸的方法
CN86104864A (zh) * 1986-07-30 1988-02-10 丹东市生物化学研究所 复合氨基酸提取方法
JPH0624976A (ja) * 1992-07-10 1994-02-01 Rikagaku Kenkyusho 輸液用組成物
DE69331528T2 (de) * 1992-12-23 2002-10-31 Abbott Laboratories, Abbott Park Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
EP0873754B1 (de) * 1996-01-09 2003-07-30 Riken Aminosäurezusammensetzungen
KR100481379B1 (ko) * 1996-05-23 2005-05-16 오쓰까 세이야꾸 가부시키가이샤 체지방률을낮추고체조성을개선시키는식품조성물및체지방률을낮추고체조성을개선시키는방법
US6221836B1 (en) 1996-07-26 2001-04-24 Paxton King Beale Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal
ES2132021B1 (es) * 1997-05-28 2000-02-16 Riera Simon Schwartz Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.
JPH10330264A (ja) * 1997-06-02 1998-12-15 Takeda Shokuhin Kogyo Kk 脂質代謝促進組成物
JP3719478B2 (ja) * 1998-03-13 2005-11-24 日本化薬株式会社 ダイエット食品
JP2000228967A (ja) * 1999-02-12 2000-08-22 Bigguuesuto Sha:Kk 脂質代謝加工食品
US7223417B2 (en) * 2000-10-27 2007-05-29 Calton Gary J Nutrient formulations
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides

Also Published As

Publication number Publication date
JP4128524B2 (ja) 2008-07-30
CN100464647C (zh) 2009-03-04
KR100753879B1 (ko) 2007-09-03
AU2008203461A1 (en) 2008-08-21
EP1402788A1 (de) 2004-03-31
KR100852930B1 (ko) 2008-08-19
KR20040016880A (ko) 2004-02-25
JPWO2002100193A1 (ja) 2005-01-13
NZ569905A (en) 2010-09-30
KR20070074002A (ko) 2007-07-10
EP1402788B1 (de) 2008-12-31
TWI328450B (en) 2010-08-11
US20040235923A1 (en) 2004-11-25
DE60230621D1 (de) 2009-02-12
CA2449917C (en) 2009-09-22
CN1538812A (zh) 2004-10-20
AU2008203461B2 (en) 2010-04-01
HK1064566A1 (en) 2005-02-04
EP1402788A4 (de) 2006-03-22
CA2449917A1 (en) 2002-12-19
WO2002100193A1 (en) 2002-12-19
NZ587048A (en) 2012-03-30

Similar Documents

Publication Publication Date Title
EP1629840A4 (de) Aminosäure-zusammensetzung und flüssigkeitsersatz
ATE418877T1 (de) Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung
CY1109304T1 (el) Αμινοξεα με συναφεια για την αλφα-2-δελτα-πρωτεϊνη
WO2002062844A3 (en) Long lasting growth hormone releasing factor derivatives
BRPI0512396A (pt) polipeptìdeos biossintéticos utilizando aminoácidos codificados não naturalmente
PL344752A1 (en) Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
ATE343332T1 (de) Zusammensetzung, welche aminosäuren und trehalose enthält
ATE245999T1 (de) Aminosäurezusammensetzungen
TW200634051A (en) Processes for preparing a polypeptide
SE0002202D0 (sv) New peptides
DE69922819D1 (de) Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie
WO2007133642A8 (en) Sport drink containing amino acids and carbohydrates
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
MX2009003126A (es) Agente para prevenir/tratar el cancer.
PE20070033A1 (es) Concentrado de proteina y flujo acuoso que contiene carbohidratos solubles de agua
NZ579566A (en) Modified fgf-21 polypeptides and their uses
WO2005034932A3 (en) Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
HK1088849A1 (en) Blood-viscosity reducing agent
DE60233558D1 (de) Aminosäurezusammensetzungen zur linderung einer fehlfunktion der leber
WO2006005455A3 (en) Amino, amino acid or peptide conjugates of retinoic acid
EP1908492A4 (de) Metabotroper glutamat-rezeptor-aktivator
IN2015DN03883A (de)
ATE245439T1 (de) Inhibitoren für homöostase und immunfunktion
WO2001097785A3 (en) Basic copolymers for the treatment of prion-related-disease
EP1641813A4 (de) Verfahren zur herstellung von molekülen mit verminderter immunogenität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties